Certified by Founder Lodge
TRIMTECH Therapeutics Limited
United Kingdom - Cambridge, England
START UP
1 Disclosed Funding Rounds $31,000,000
0 Participating Investments
-
Founded date
2023
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
TRIMTECH has a growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs and TRIMGLUEs. The pipelin
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 07 ,2025 | Seed | $31,000,000 |
Eli Lilly and Company
SV Health Investors
Cambridge Innovation Capital
M Ventures(Netherlands)
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
BuildVision | $10,000,000 | (Mar 28, 2025)
Nanoprecise Sci Corp | $38,000,000 | (Mar 28, 2025)
Mendel | $35,000,000 | (Mar 28, 2025)
MemryX Inc. | $44,000,000 | (Mar 28, 2025)
Galatea Bio Inc. | $25,000,000 | (Mar 28, 2025)
